Energy & environment · 04/02/2009Updated: 10/17/2026 · 1 min read
Signum Biosciences, Inc. Seeks Approval for Unrestricted Release of New Jersey Facility
Summary
Signum Biosciences, Inc. has submitted a license amendment request to the U.S. Nuclear Regulatory Commission (NRC) for unrestricted release of its facility in Monmouth Junction, NJ, following the completion of an environmental assessment and finding of no significant impact.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →